Plant ID: NPO21451
Plant Latin Name: Thalictrum simplex
Taxonomy Genus: Thalictrum
Taxonomy Family: Ranunculaceae
NCBI TaxonomyDB:
495765
Plant-of-the-World-Online:
304708-2
Ukraine; Hungary; Belarus; Italy; Denmark; Poland; Finland; Romania; France; Switzerland; Austria; China; Greece; Sweden; Germany; Norway; Russia; Bulgaria
GRM5; GRM1; | |
TDP1; BLM; ALDH1A1; | |
GAA; | |
FOLH1; | |
NFKB1; | |
SLC7A11; | |
SMN1;SMN2; | |
LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Metallo protease | FOLH1 | Glutamate carboxypeptidase II | Q04609 | CHEMBL1892 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
SLC superfamily of solute carriers | SLC7A11 | Cystine/glutamate transporter | Q9UPY5 | CHEMBL1075149 |
Small molecule receptor (family C GPCR) | GRM5 | Metabotropic glutamate receptor 5 | P41594 | CHEMBL3227 |
Small molecule receptor (family C GPCR) | GRM1 | Metabotropic glutamate receptor 1 | Q13255 | CHEMBL3772 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | Unclassified; | GO:0099566; regulation of postsynaptic cytosolic calcium ion concentration | 1.463E-06 | 1.062E-02 | GRM1, GRM5 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 1.463E-06 | 1.062E-02 | CYP2D6, CYP3A4 |
MF | GO:0060089; molecular transducer activity | GO:0099583; neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.463E-06 | 1.062E-02 | GRM1, GRM5 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 7.305E-06 | 3.977E-02 | CYP2D6, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 9.229E-04 | 2.470E-02 | ALDH1A1, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04720 | Long-term potentiation | 9.514E-04 | 2.470E-02 | GRM5, GRM1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.039E-03 | 2.470E-02 | CYP2D6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.162E-03 | 2.470E-02 | CYP2D6, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04723 | Retrograde endocannabinoid signaling | 2.209E-03 | 3.129E-02 | GRM5, GRM1 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04540 | Gap junction | 1.683E-03 | 2.861E-02 | GRM5, GRM1 |
09150 Organismal Systems | 09156 Nervous system | hsa04724 | Glutamatergic synapse | 2.802E-03 | 3.403E-02 | GRM5, GRM1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 4.190E-03 | 4.180E-02 | LMNA, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04072 | Phospholipase D signaling pathway | 4.426E-03 | 4.180E-02 | GRM5, GRM1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04020 | Calcium signaling pathway | 6.827E-03 | 5.275E-02 | GRM5, GRM1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | GRM1; GRM5; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; GRM5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
G00-G99: Diseases of the nervous system G00-G99 | Chronic neuropathic pain | G64, G90.0, K21, R52, G89 | GRM5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | GRM1; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | GRM5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Autism | F84.0 | GRM5; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | GRM1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Fragile X syndrome | F02.3, G20, Q99.2 | GRM5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | GRM5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Huntington's disease | F02.2, G10 | GRM1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mood disorder | F30-F39 | GRM5; |
NA: NA | GERD | NA | GRM5; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; GRM5; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | GRM1; GRM5; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | GRM1; GRM5; |